My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Sierra Oncology, Inc. - Common Stock (NQ:SRRA)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 30, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Sierra Oncology, Inc. - Common Stock

Sierra Oncology's Bet On A Failed Gilead Drug Just Paid Off In A Big Way ↗

January 25, 2022

Sierra Oncology spent just $3 million up front to acquire momelotinib.

Via Investor's Business Daily

Sierra Oncology Secures Debt Facility Of Up To $125M With Oxford Finance To Support Momelotinib Development ↗

January 25, 2022

Sierra Oncology Inc (NASDAQ: SRRA) has entered into a term loan agreement with Oxford Finance LLC to support the commercial preparation and potential...

Via Benzinga

Sierra Oncology Shares Rally As Bone Marrow Cancer Candidate Hits Primary Goal ↗

January 25, 2022

Sierra Oncology Inc (NASDAQ: SRRA) unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic, anemic, and previously treated with an FDA-...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 25, 2022

Gainers Sierra Oncology (NASDAQ:SRRA) stock rose 45.6% to $22.58 during Tuesday's pre-market session. The market value of their outstanding shares is at $339.9 million...

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data ↗

January 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2021 ↗

September 27, 2021

Upgrades According to Roth Capital, the prior rating for Seelos Therapeutics Inc (NASDAQ:

Via Benzinga

Sierra Oncology Bets $216M On AstraZeneca's BET Inhibitor For Myelofibrosis ↗

August 06, 2021

Sierra Oncology Inc (NASDAQ: SRRA) has acquired an exclusive global license from AstraZeneca Plc (NASDAQ: AZN) for AZD5153, a potent, and selective BRD4...

Via Benzinga

The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗

August 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗

July 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

58 Biggest Movers From Yesterday ↗

July 13, 2021

Gainers MediaCo Holding Inc. (NASDAQ: MDIA) shares jumped 311.6% to close at $17.00 on Monday after jumping 20% on Friday. State Auto Financial Corporation (NASDAQ: STFC) shares...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.